fda food and drug administration

FDA to put most serious warning on COVID-19 vaccines

Covid Shots May Get FDA’s Strongest Warning

The Food and Drug Administration is considering whether to place a “black-box” warning —a high-danger label only used to flag risk of death, severe harm, or incapacitation—on Covid vaccines, CNN has r...

· 1d · on MSN

FDA intends to put most serious warning on COVID vaccines, CNN reports

Scientific American · 1d

Health Experts Slam Possible FDA ‘Black Box’ Warning for COVID Vaccines

· 1d

FDA intends to put its most serious warning on Covid vaccines, sources say

The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans.

· 1d

Some P.E.I. pharmacies seeing a shortage of COVID-19 vaccines

· 1d

FDA to update regulations after unconfirmed claims of Covid vaccine-linked death

FDA proposes new sunscreen ingredient—here’s why it matters

Digest more

· 1d · on MSN

FDA proposes allowing sunscreen ingredient already used in Europe and Asia

The Food and Drug Administration announced a proposal Thursday to make another sunscreen ingredient available to U.S. manufacturers.

· 1d · on MSN

FDA moves to expand sunscreen options, proposing ingredient used in Asia and Europe

· 1d · on MSN

FDA considering allowing new sunscreen ingredient in US

3don MSN

FDA opens safety review of injectable RSV drugs approved for babies and toddlers

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and toddlers from RSV, the respiratory virus that sends thousands of American children to the hospital each year.

1don MSN

FDA approves BioCryst's oral pellet version of rare disease drug for children

The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent hereditary angioedema attacks in children aged 2 to under 12, the company said on Friday.

Tri-State Livestock News

FDA Conditionally Approves Topical Drug for Cattle for New World Screwworm and Cattle Fever Tick

Today, the U.S. Food and Drug Administration conditionally approved Exzolt Cattle-CA1 (fluralaner) topical solution for the prevention and treatment of New World screwworm (NWS) larval infestations, and the treatment and control of cattle fever tick in

3don MSN

FDA launches safety review of RSV infant drugs as RFK Jr. scrutinizes immunizations

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary Robert F. Kennedy Jr.

3don MSN

US FDA approves first drug under new fast-track review program

The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application.

1don MSN

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is growing harder to treat,

STAT

FDA approves first new kind of drug to target gonorrhea in decades

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections in decades, and the first developed as part of a public-private partnership.

The Manila Times

Ophirex Announces Business Update: Advances Toward Food and Drug Administration (FDA) Approval for Varespladib as Novel Oral Snakebite Treatment

Ophirex announced that varespladib, which is also being developed as an oral rescue treatment for snakebite envenomation in dogs, has received MUMS designation for minor use in a major species from the FDA Center for Veterinary Medicine for the treatment of snakebite in dogs.